| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $11K | +0.0% | -85.0% |
| SG&A Expense | $144K | +63.4% | +150.0% |
| Interest Expense | $12K | +40.7% | — |
| Net Income | -$167K | -55.4% | -30.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $59K | -41.3% | -61.1% |
| Current Assets | $99K | -38.3% | -39.5% |
| Total Assets | $235K | -21.9% | +28.2% |
| Current Liabilities | $104K | +59.7% | +116.7% |
| Total Liabilities | $667K | +17.8% | +190.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$92K | — | +12.3% |
| Financing Cash Flow | $50K | — | -72.2% |
| -$432K |
| -63.1% |
| -841.8% |